KLK3 and posterior cortical atrophy: With this extremely sensitive technology, we now have a tool for improved patient selection — to identify patients with purely locally advanced PCa, detect minimal lymph node involvement, and enable reliable post-operative follow-up in patients with undetectable or low PSA levels, thus allowing for early salvage treatment of metastases.